Drug Scientists Slow to Adopt Open Source

By M.L. Baker  |  Posted 09-08-2005 Print Email
A surge in open-source technology has given many businesses more options for powerful, low-cost software. But the pharmaceutical industry remains well behind the curve.


Submit a Comment

Loading Comments...
Thanks for your registration, follow us on our social networks to keep up-to-date